Why a randomized melanoma screening trial may be a good idea
Br J Dermatol
.
2018 Nov;179(5):1227-1228.
doi: 10.1111/bjd.17089.
Epub 2018 Sep 20.
Authors
A E Cust
1
2
,
J F Aitken
3
4
,
P D Baade
3
5
,
D C Whiteman
6
,
H P Soyer
7
8
,
M Janda
9
Affiliations
1
Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, Sydney, Australia.
2
Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
3
Cancer Council Queensland, Brisbane, Australia.
4
Menzies Health Institute, Griffith University, Southport, QLD, Australia.
5
School of Mathematical Sciences, Queensland University of Technology, Brisbane, Australia.
6
QIMR-Berghofer Medical Research Institute, Brisbane, Australia.
7
Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Brisbane, Australia.
8
Dermatology Department, Princess Alexandra Hospital, Brisbane, Australia.
9
Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Princess Alexandra Hospital, Brisbane, Australia.
PMID:
30101459
DOI:
10.1111/bjd.17089
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Mass Screening
Melanoma*
Skin Neoplasms*